28
Participants
Start Date
July 31, 2002
Primary Completion Date
July 31, 2006
Study Completion Date
September 30, 2006
Pentostatin
2 mg/m2 IV over 30 minutes in 250 mL NS on day 1 during cycles 1-6.
Rituximab
For the first week only: Day 1 of therapy 100 mg IV over 4 hours. Day 3 of therapy 375 mg/m2 IV at 50 mg/hr and increase by 100 mg/hr at 30-minute intervals to a maximum of 400 mg/hr. Day 5 of therapy 375 mg/m2 IV at 100 mg/hr for the first 15 minutes the remainder goes in at 45 minutes. The remaining weeks 375 mg/m2 will be repeated as a single IV infusion Day 1 of Week 4, 7, 10, 13 and 16 during cycles 2-6.
Cyclophosphamide
600 mg/m2 IV in 250 mL NS over 30 minutes on day 1 cycles 1-6
Ohio State University, Columbus
Collaborators (1)
Astex Pharmaceuticals, Inc.
INDUSTRY
Ohio State University Comprehensive Cancer Center
OTHER